Delisting riskPopularity #4,241
Daré Bioscience (DARE)
Develops women's-health products spanning contraception, sexual health, menopause and vaginal health.
$0.8092
vs last close−0.04 (−4.80%)
Something off on this page? Send us feedback.
Next report
Nov 12, 26
in 50 days
EPS estimate
−$0.14
Revenue estimate
$2.0M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$0.64−$0.50−$0.45−$0.28−$0.02−$0.20−$0.20Pending
Estimate−$0.66−$0.63−$0.55−$0.33−$0.24−$0.33−$0.30−$0.14
Surprise+3.0%+20.6%+18.2%+15.2%+91.7%+39.4%+32.6%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$63.6K$25.4K−$21.2K$2.3K$1.0M$152.5K$187.5KPending
Estimate$1.0M$600.0K$147.3K$765.0K$751.5K$27.0K$1.7K$2.0M
Surprise−106.4%−95.8%−114.4%−99.7%+36.2%+464.6%+11,150.5%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2028 | $0.00 | — | — |
| Sep 2028 | $0.00 | — | — |
| Jun 2028 | $0.00 | — | — |
| Mar 2028 | $0.00 | — | — |
| Dec 2027 | −$0.09 | — | — |
| Sep 2027 | −$0.10 | — | — |
| Jun 2027 | −$0.13 | — | — |
| Mar 2027 | −$0.11 | — | — |
| Dec 2026 | −$0.23 | — | — |
| Nov 2026 | −$0.14 | — | — |
| Aug 2026 | −$0.30 | −$0.20 | +32.6% |
| May 2026 | −$0.33 | −$0.20 | +39.4% |
| Mar 2026 | −$0.24 | −$0.02 | +91.7% |
| Nov 2025 | −$0.33 | −$0.28 | +15.2% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Mar 2024 | |||
| Dec 2023 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Apr 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Mar 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2028 | $0.00 | — | — | $12.2M | — | — | — |
| Sep 2028 | $0.00 | — | — | $11.8M | — | — | — |
| Jun 2028 | $0.00 | — | — | $10.9M | — | — | — |
| Mar 2028 | $0.00 | — | — | $10.4M | — | — | — |
| Dec 2027 | −$0.09 | — | — | $2.9M | — | — | — |
| Sep 2027 | −$0.10 | — | — | $2.3M | — | — | — |
| Jun 2027 | −$0.13 | — | — | $2.0M | — | — | — |
| Mar 2027 | −$0.11 | — | — | $1.7M | — | — | — |
| Dec 2026 | −$0.23 | — | — | $359.3K | — | — | — |
| Nov 12, 2026 | −$0.14 | — | — | $2.0M | — | — | — |
| Aug 13, 2026 | −$0.30 | −$0.20 | +32.6% | $1.7K | $187.5K | +11,150.5% | −32.1% |
| May 14, 2026 | −$0.33 | −$0.20 | +39.4% | $27.0K | $152.5K | +464.6% | −24.1% |
| Mar 26, 2026 | −$0.24 | −$0.02 | +91.7% | $751.5K | $1.0M | +36.2% | +2.7% |
| Nov 13, 2025 | −$0.33 | −$0.28 | +15.2% | $765.0K | $2.3K | −99.7% | −1.6% |
| Aug 14, 2025 | |||||||
| May 13, 2025 | |||||||
| Mar 31, 2025 | |||||||
| Nov 14, 2024 | |||||||
| Aug 12, 2024 | |||||||
| May 14, 2024 | |||||||
| Mar 28, 2024 | |||||||
| Dec 30, 2023 | |||||||
| Nov 9, 2023 | |||||||
| Aug 10, 2023 | |||||||
| May 11, 2023 | |||||||
| Mar 30, 2023 | |||||||
| Nov 10, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 31, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 12, 2021 | |||||||
| May 13, 2021 | |||||||
| Mar 30, 2021 | |||||||
| Nov 12, 2020 | |||||||
| Aug 12, 2020 | |||||||
| May 14, 2020 | |||||||
| Mar 30, 2020 | |||||||
| Nov 14, 2019 | |||||||
| Aug 14, 2019 | |||||||
| May 14, 2019 | |||||||
| Apr 1, 2019 | |||||||
| Nov 13, 2018 | |||||||
| Aug 13, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 29, 2018 | |||||||
| Nov 13, 2017 | |||||||
| Aug 14, 2017 | |||||||
| May 12, 2017 | |||||||
| Mar 31, 2017 | |||||||
| Nov 3, 2016 | |||||||
| Aug 4, 2016 | |||||||
| May 2, 2016 | |||||||
| Mar 10, 2016 | |||||||
| Nov 16, 2015 |